Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.

Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG, Lofano G, Marchi S, Galletti B, Mariotti P, Bacconi M, Torre A, Maccari S, Scarselli M, Rinaudo CD, Inoshima N, Savino S, Mori E, Rossi-Paccani S, Baudner B, Pallaoro M, Swennen E, Petracca R, Brettoni C, Liberatori S, Norais N, Monaci E, Bubeck Wardenburg J, Schneewind O, O'Hagan DT, Valiante NM, Bensi G, Bertholet S, De Gregorio E, Rappuoli R, Grandi G.

Proc Natl Acad Sci U S A. 2015 Mar 24;112(12):3680-5. doi: 10.1073/pnas.1424924112. Epub 2015 Mar 9.

2.

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Micoli F, Romano MR, Tontini M, Cappelletti E, Gavini M, Proietti D, Rondini S, Swennen E, Santini L, Filippini S, Balocchi C, Adamo R, Pluschke G, Norheim G, Pollard A, Saul A, Rappuoli R, MacLennan CA, Berti F, Costantino P.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19077-82. doi: 10.1073/pnas.1314476110. Epub 2013 Nov 4.

3.

Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Leuzzi R, Spencer J, Buckley A, Brettoni C, Martinelli M, Tulli L, Marchi S, Luzzi E, Irvine J, Candlish D, Veggi D, Pansegrau W, Fiaschi L, Savino S, Swennen E, Cakici O, Oviedo-Orta E, Giraldi M, Baudner B, D'Urzo N, Maione D, Soriani M, Rappuoli R, Pizza M, Douce GR, Scarselli M.

Infect Immun. 2013 Aug;81(8):2851-60. doi: 10.1128/IAI.01341-12. Epub 2013 May 28.

4.

Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide.

Adamo R, Romano MR, Berti F, Leuzzi R, Tontini M, Danieli E, Cappelletti E, Cakici OS, Swennen E, Pinto V, Brogioni B, Proietti D, Galeotti CL, Lay L, Monteiro MA, Scarselli M, Costantino P.

ACS Chem Biol. 2012 Aug 17;7(8):1420-8. doi: 10.1021/cb300221f. Epub 2012 Jun 7.

PMID:
22620974
5.

Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.

Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, Capo S, Falugi F, Manetti AG, Donato P, Swennen E, Gallotta M, Garibaldi M, Pinto V, Chiappini N, Musser JM, Janulczyk R, Mariani M, Scarselli M, Telford JL, Grifantini R, Norais N, Margarit I, Grandi G.

Mol Cell Proteomics. 2012 Jun;11(6):M111.015693. doi: 10.1074/mcp.M111.015693. Epub 2012 Jan 27.

6.

The new pLAI (lux regulon based auto-inducible) expression system for recombinant protein production in Escherichia coli.

Nocadello S, Swennen EF.

Microb Cell Fact. 2012 Jan 5;11:3. doi: 10.1186/1475-2859-11-3.

7.

Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation.

Snoeijs MG, van Bijnen A, Swennen E, Haenen GR, Roberts LJ 2nd, Christiaans MH, Peppelenbosch AG, Buurman WA, Ernest van Heurn LW.

Ann Surg. 2011 Mar;253(3):598-604. doi: 10.1097/SLA.0b013e31820d9ae9.

PMID:
21248631
8.

Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate.

Kabanova A, Margarit I, Berti F, Romano MR, Grandi G, Bensi G, Chiarot E, Proietti D, Swennen E, Cappelletti E, Fontani P, Casini D, Adamo R, Pinto V, Skibinski D, Capo S, Buffi G, Gallotta M, Christ WJ, Campbell AS, Pena J, Seeberger PH, Rappuoli R, Costantino P.

Vaccine. 2010 Dec 10;29(1):104-14. doi: 10.1016/j.vaccine.2010.09.018. Epub 2010 Sep 24.

PMID:
20870056
9.

ATP sensitizes H460 lung carcinoma cells to cisplatin-induced apoptosis.

Swennen EL, Ummels V, Buss I, Jaehde U, Bast A, Dagnelie PC.

Chem Biol Interact. 2010 Mar 30;184(3):338-45. doi: 10.1016/j.cbi.2010.02.011. Epub 2010 Feb 13.

PMID:
20156429
10.

Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants.

Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR.

Respir Med. 2009 Mar;103(3):364-72. doi: 10.1016/j.rmed.2008.10.007. Epub 2008 Nov 17.

11.

In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers.

Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR.

Nutrition. 2008 Jul-Aug;24(7-8):703-10. doi: 10.1016/j.nut.2008.03.023.

PMID:
18549926
12.

Time-dependent effects of ATP and its degradation products on inflammatory markers in human blood ex vivo.

Swennen EL, Coolen EJ, Arts IC, Bast A, Dagnelie PC.

Immunobiology. 2008;213(5):389-97. doi: 10.1016/j.imbio.2007.10.007. Epub 2007 Nov 26.

PMID:
18472047
13.

Simultaneous determination of adenosine triphosphate and its metabolites in human whole blood by RP-HPLC and UV-detection.

Coolen EJ, Arts IC, Swennen EL, Bast A, Stuart MA, Dagnelie PC.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):43-51. doi: 10.1016/j.jchromb.2008.01.033. Epub 2008 Jan 31.

PMID:
18282748
14.

Radioprotective effects of ATP in human blood ex vivo.

Swennen EL, Dagnelie PC, Van den Beucken T, Bast A.

Biochem Biophys Res Commun. 2008 Mar 7;367(2):383-7. doi: 10.1016/j.bbrc.2007.12.125. Epub 2007 Dec 28.

PMID:
18164682
15.

Purinergic receptors involved in the immunomodulatory effects of ATP in human blood.

Swennen EL, Bast A, Dagnelie PC.

Biochem Biophys Res Commun. 2006 Sep 29;348(3):1194-9. Epub 2006 Aug 4.

PMID:
16904065
16.

Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC.

Pharmacol Ther. 2006 Nov;112(2):358-404. Epub 2006 Jun 19. Review.

PMID:
16784779
17.

Solution structure of the immunodominant domain of protective antigen GNA1870 of Neisseria meningitidis.

Cantini F, Savino S, Scarselli M, Masignani V, Pizza M, Romagnoli G, Swennen E, Veggi D, Banci L, Rappuoli R.

J Biol Chem. 2006 Mar 17;281(11):7220-7. Epub 2005 Dec 31.

19.
20.

PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption.

Brigidi P, Swennen E, Vitali B, Rossi M, Matteuzzi D.

Int J Food Microbiol. 2003 Mar 25;81(3):203-9.

PMID:
12485746
21.

Variable response to probiotics in two models of experimental colitis in rats.

Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D.

Inflamm Bowel Dis. 2002 Nov;8(6):399-406.

PMID:
12454615
22.

Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis.

Brigidi P, Swennen E, Rizzello F, Bozzolasco M, Matteuzzi D.

J Chemother. 2002 Jun;14(3):290-5.

PMID:
12120885
23.

Effect of probiotic strains on interleukin 8 production by HT29/19A cells.

Lammers KM, Helwig U, Swennen E, Rizzello F, Venturi A, Caramelli E, Kamm MA, Brigidi P, Gionchetti P, Campieri M.

Am J Gastroenterol. 2002 May;97(5):1182-6.

PMID:
12014725
24.
25.

Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.

Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C.

Kidney Int. 2001 Sep;60(3):1097-105.

26.

Specific detection of bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction.

Brigidi P, Vitali B, Swennen E, Altomare L, Rossi M, Matteuzzi D.

Syst Appl Microbiol. 2000 Oct;23(3):391-9.

PMID:
11108019

Supplemental Content

Loading ...
Support Center